AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE2081.752.05 (+0.1 %)
PREV CLOSE ( ) 2079.70
OPEN PRICE ( ) 2063.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1788
TODAY'S LOW / HIGH ( )2063.45 2103.50
52 WK LOW / HIGH ( )1240.55 2355.05
NSE2085.406.55 (+0.32 %)
PREV CLOSE( ) 2078.85
OPEN PRICE ( ) 2078.85
BID PRICE (QTY) 2085.40 (2)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 34465
TODAY'S LOW / HIGH( ) 2069.15 2107.95
52 WK LOW / HIGH ( )1246.75 2353.95
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax7452.509094.809001.806639.705142.70
Adjustment1313.00917.501152.70707.90619.30
Changes In working Capital665.20-2003.90-2087.50-1231.60-834.60
Cash Flow after changes in Working Capital9430.708008.408067.006116.004927.40
Cash Flow from Operating Activities7917.805617.105763.104567.703745.10
Cash Flow from Investing Activities-5596.00-741.00-2823.80-2244.00-2227.80
Cash Flow from Financing Activities-1078.70-4597.10-3182.90-1286.30-1474.60
Net Cash Inflow / Outflow1243.10279.00-243.601037.4042.70
Opening Cash & Cash Equivalents2063.601775.102023.50951.60906.40
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent3306.702054.101779.901989.00949.10

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.